Tumorigenesis suppressor Pdcd4 down-regulates mitogen-activated protein kinase kinase kinase kinase 1 expression to suppress colon carcinoma cell invasion

被引:192
作者
Yang, HS
Matthews, CP
Clair, T
Wang, Q
Baker, AR
Li, CCH
Tan, TH
Colburn, NH
机构
[1] NCI, Canc Res Ctr, Lab Canc Prevent, Ft Detrick, MD 21702 USA
[2] NCI, Pathol Lab, Bethesda, MD 20892 USA
[3] SAIC Frederick, Basic Res Program, Frederick, MD 21702 USA
[4] Bayer Coll Med, Dept Immunol, Houston, TX 77030 USA
关键词
D O I
10.1128/MCB.26.4.1297-1306.2006
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Programmed cell death 4 (Pdcd4) suppresses neoplastic transformation by inhibiting the activation of c-Jun and consequently AP-1-dependent transcription. We report that Pdcd4 blocks c-Jun activation by inhibiting the expression of mitogen-activated protein kinase kinase kinase kinase 1 (MAP4K1)/hematopoietic progenitor kinase 1, a kinase upstream of Jun N-terminal kinase (JNK). cDNA microarray analysis of Pdcd4-overexpressing RKO human colon carcinoma cells revealed MAP4K1 as the sole target of Pdcd4 on the JNK activation pathway. Cotransfection of a MAP4K1 promoter-reporter with Pdcd4 demonstrated inhibition of transcription from the MANK1 promoter. Ectopic expression of Pdcd4 in metastatic RKO cells suppressed invasion. MAP4K1 activity is functionally significant in invasion, as overexpression of a dominant negative MAP4K1 (dnMAP4KI) mutant in RKO cells inhibited not only c-Jun activation but also invasion. Overexpression of a MAP4K1 cDNA in Pdcd4-transfected cells rescued the kinase activity of JNK. Thus, Pdcd4 suppresses tumor progression in human colon carcinoma cells by the novel mechanism of down-regulating MAP4K1 transcription, with consequent inhibition of c-Jun activation and AP-1-dependent transcription.
引用
收藏
页码:1297 / 1306
页数:10
相关论文
共 53 条
[41]   Isolation of a novel mouse gene MA-3 that is induced upon programmed cell death [J].
Shibahara, K ;
Asano, M ;
Ishida, Y ;
Aoki, T ;
Koike, T ;
Honjo, T .
GENE, 1995, 166 (02) :297-301
[42]   c-Jun N-terminal kinase is involved in motility of endothelial cell [J].
Shin, EY ;
Kim, SY ;
Kim, EG .
EXPERIMENTAL AND MOLECULAR MEDICINE, 2001, 33 (04) :276-283
[43]   An inhibitor of c-jun aminoterminal kinase (SP600125) represses c-Jun activation, DNA-binding and PMA-inducible 92-kDa type IV collagenase expression [J].
Shin, M ;
Yan, C ;
Boyd, D .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2002, 1589 (03) :311-316
[44]   Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases [J].
Taguchi, A ;
Blood, DC ;
del Toro, G ;
Canet, A ;
Lee, DC ;
Qu, W ;
Tanji, N ;
Lu, Y ;
Lalla, E ;
Fu, CF ;
Hofmann, MA ;
Kislinger, T ;
Ingram, M ;
Lu, A ;
Tanaka, H ;
Hori, O ;
Ogawa, S ;
Stern, DM ;
Schmidt, AM .
NATURE, 2000, 405 (6784) :354-360
[45]   Role of Jun and Jun kinase in resistance of cancer cells to therapy [J].
Vasilevskaya, I ;
O'Dwyer, PJ .
DRUG RESISTANCE UPDATES, 2003, 6 (03) :147-156
[46]   A novel function of the MA-3 domains in transformation and translation suppressor Pdcd4 is essential for its binding to eukaryotic translation initiation factor 4A [J].
Yang, HS ;
Cho, MH ;
Zakowicz, H ;
Hegamyer, G ;
Sonenberg, N ;
Colburn, NH .
MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (09) :3894-3906
[47]   Pdcd4 suppresses tumor phenotype in JB6 cells by inhibiting AP-1 transactivation [J].
Yang, HS ;
Knies, JL ;
Stark, C ;
Colburn, NH .
ONCOGENE, 2003, 22 (24) :3712-3720
[48]   A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-κB or ODC transactivation [J].
Yang, HS ;
Jansen, AP ;
Nair, R ;
Shibahara, K ;
Verma, AK ;
Cmarik, JL ;
Colburn, NH .
ONCOGENE, 2001, 20 (06) :669-676
[49]  
Yang Ling, 2003, Asian Pac J Cancer Prev, V4, P23
[50]   The pathogenesis of squamous cell cancer: lessons learned from studies of skin carcinogenesis [J].
Yuspa, SH .
JOURNAL OF DERMATOLOGICAL SCIENCE, 1998, 17 (01) :1-7